Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin II as a cardiovascular risk factor.

I Gavras1, H Gavras

  • 1Hypertension and Atherosclerosis Section, Department of Medicine, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.

Journal of Human Hypertension
|April 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension.

Journal of human hypertension·2014
Same author

Sympathetic overactivity in hypertension and cardiovascular disease.

Current vascular pharmacology·2013
Same author

Angiotensin inhibition and malignancies: a review.

Journal of human hypertension·2009
Same author

Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?

Kidney & blood pressure research·2006
Same author

A free-ranging roundtable discussion on hypertension.

Journal of human hypertension·2005
Same author

Association between hypervolemia and ventricular hypertrophy in hemodialysis patients.

American journal of hypertension·2004

High renin-angiotensin levels are a modifiable cardiovascular risk factor. This system contributes to heart damage through various mechanisms, including ischemia and hypertrophy, impacting cardiac health.

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Cardiac Pathophysiology

Background:

  • Elevated renin-angiotensin system (RAS) activity is a recognized cardiovascular risk factor.
  • Angiotensin exerts effects both systemically and locally within cardiac structures.
  • RAS activation contributes to adverse cardiac remodeling and dysfunction.

Purpose of the Study:

  • To review the mechanisms by which RAS activation damages the heart.
  • To highlight the role of RAS in cardiovascular risk.
  • To discuss the link between RAS and myocardial injury.

Main Methods:

  • Literature review of studies on renin-angiotensin system and cardiac damage.
  • Analysis of hemodynamic and humoral consequences of RAS activation.

Related Experiment Videos

  • Examination of molecular and cellular effects on the myocardium.

    • Main Results:

    • RAS activation leads to myocardial ischemia, left-ventricular hypertrophy, and arrhythmias.
    • It alters coagulation-fibrinolysis balance, increases oxidative stress, and promotes inflammation.
    • Both mechanical and neurohumoral effects contribute to cardiac damage.

    Conclusions:

    • Inappropriately high RAS activity is a modifiable factor contributing to heart disease.
    • RAS activation initiates multiple pathways leading to myocardial injury.
    • Understanding these mechanisms is crucial for cardiovascular risk management.